1. Home
  2. RIGL vs QSG Comparison

RIGL vs QSG Comparison

Compare RIGL & QSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RIGL
  • QSG
  • Stock Information
  • Founded
  • RIGL 1996
  • QSG 2019
  • Country
  • RIGL United States
  • QSG China
  • Employees
  • RIGL N/A
  • QSG N/A
  • Industry
  • RIGL Biotechnology: Pharmaceutical Preparations
  • QSG Other Consumer Services
  • Sector
  • RIGL Health Care
  • QSG Real Estate
  • Exchange
  • RIGL Nasdaq
  • QSG Nasdaq
  • Market Cap
  • RIGL 335.5M
  • QSG 360.9M
  • IPO Year
  • RIGL 2000
  • QSG 2023
  • Fundamental
  • Price
  • RIGL $18.98
  • QSG $8.91
  • Analyst Decision
  • RIGL Buy
  • QSG Buy
  • Analyst Count
  • RIGL 5
  • QSG 2
  • Target Price
  • RIGL $36.40
  • QSG $5.81
  • AVG Volume (30 Days)
  • RIGL 206.5K
  • QSG 2.0M
  • Earning Date
  • RIGL 08-05-2025
  • QSG 08-27-2025
  • Dividend Yield
  • RIGL N/A
  • QSG 2.02%
  • EPS Growth
  • RIGL N/A
  • QSG 92.28
  • EPS
  • RIGL 2.08
  • QSG 1.12
  • Revenue
  • RIGL $203,077,000.00
  • QSG $428,283,608.00
  • Revenue This Year
  • RIGL $14.41
  • QSG N/A
  • Revenue Next Year
  • RIGL $15.97
  • QSG N/A
  • P/E Ratio
  • RIGL $9.41
  • QSG $8.72
  • Revenue Growth
  • RIGL 70.16
  • QSG N/A
  • 52 Week Low
  • RIGL $8.10
  • QSG $1.50
  • 52 Week High
  • RIGL $29.82
  • QSG $15.64
  • Technical
  • Relative Strength Index (RSI)
  • RIGL 45.79
  • QSG 48.62
  • Support Level
  • RIGL $18.24
  • QSG $8.63
  • Resistance Level
  • RIGL $19.38
  • QSG $10.48
  • Average True Range (ATR)
  • RIGL 0.77
  • QSG 1.34
  • MACD
  • RIGL -0.04
  • QSG -0.22
  • Stochastic Oscillator
  • RIGL 43.64
  • QSG 22.20

About RIGL Rigel Pharmaceuticals Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.

About QSG QuantaSing Group Limited

QuantaSing Group Ltd is a lifestyle solution provider. The company offers engaging, affordable, and accessible online and offline services, as well as consumer products in selected areas that address adult learners. The group has expanded into the pop toys sector and continues to strategically diversify its portfolio by capturing opportunities in consumer sectors while maintaining financial discipline.

Share on Social Networks: